Journal article icon

Journal article

Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study.

Abstract:

UNLABELLED: Once-monthly (50/50, 100, and 150 mg) and daily (2.5 mg; 3-year vertebral fracture risk reduction: 52%) oral ibandronate regimens were compared in 1609 women with postmenopausal osteoporosis. At least equivalent efficacy and similar safety and tolerability were shown after 1 year. INTRODUCTION: Suboptimal adherence to daily and weekly oral bisphosphonates can potentially compromise therapeutic outcomes in postmenopausal osteoporosis. Although yet to be prospectively shown in oste...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1359/jbmr.050313

Authors


Miller, PD More by this author
McClung, MR More by this author
Macovei, L More by this author
Stakkestad, JA More by this author
Expand authors...
Journal:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Volume:
20
Issue:
8
Pages:
1315-1322
Publication date:
2005-08-05
DOI:
EISSN:
1523-4681
ISSN:
0884-0431
URN:
uuid:84f5df77-1c41-49a8-aa05-96dca3edcf67
Source identifiers:
126429
Local pid:
pubs:126429

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP